CVB homepage

Trending

Vendor payments not responsible for rising popularity of LAAO procedures
AI helps cardiologists terminate AFib for good with ablation
FDA announces new recall of Abbott heart pump accessories over significant safety risks
Same-day discharge after cardiac ablation: Cardiologists share recommendations
PFA startup founded by industry veteran to share first-in-human data at Heart Rhythm 2025
drink champagne alcohol
Champagne could be good for the heart—and other lessons from a new risk analysis

Researchers explored the potential impact of more than 100 risk factors on a person's risk of sudden cardiac arrest. Some of their findings were what you may expect, but others were much more surprising.

Partho Sengupta, MD, DM, FACC, FASE, Henry Rutgers Professor of Cardiology and Chief of Cardiovascular Medicine, at Robert Wood Johnson Medical School, and Chief of the Cardiovascular Service Line at Robert Wood Johnson University Hospital, offers an overview of the current state of artificial intelligence (AI) in cardiology. He offers insights from what he has seen from some of the more than 160 FDA-cleared algorithms specific to cardiovascular medicine and what is in development.
Exploring the evolution of AI in cardiology

Partho Sengupta, MD, shared his perspective on the current state of artificial intelligence in cardiology. The technology continues to evolve, he said, though it does still face certain limitations.

doctor with overweight patient who may be treated with TAVR or surgery
Bayer's finerenone reduces risk of AFib, atrial flutter in all CKM syndrome patients

New data published in JACC represents another big win for Bayer's finerenone. The drug has previously been linked to cardiovascular benefits for patients with CKD and heart failure, but its potential across the full CKM spectrum remained a bit of a mystery.

Society of Thoracic Surgeons shares new risk calculator for aortic surgeries
Society of Thoracic Surgeons shares new risk calculator for complex aortic procedures

The new resource was built to help care teams plan for ascending aorta and aortic root surgeries.

Heart Rhythm 2025 Heart Rhythm Society President Kenneth A. Ellenbogen, MD
PFA takes center stage at Heart Rhythm 2025 as medtech companies share new data

Pulsed field ablation was one of the biggest topics at Heart Rhythm 2025, the annual meeting of the Heart Rhythm Society. Medtronic, Johnson & Johnson MedTech, Boston Scientific, Abbott, Kardium and Field Medical all shared new data at the conference highlighting the safety and effectiveness of their advanced PFA technologies. 

OmniaSecure defibrillation lead for placement within a patient’s right ventricle
Medtronic receives FDA approval for smallest defibrillation lead of its kind

Medtronic emphasized that this device should be especially valuable when treating younger patients or those with a small anatomy.

robotic assisted robotic surgery robot
Robotic mitral valve repair linked to benefits for elderly patients

Robotic and traditional mitral valve repair surgeries are mostly associated with similar outcomes when treating elderly patients. In some ways, however, robotic procedures may be preferred. 

Alexander Kolomaya, MD, a cardiology resident at the University of Utah, presented a study on U.S. national trends in left atrial appendage occlusion (LAAO) volume and open payments from vendors to operators at the American Heart Association 2024 meeting.
Vendor payments not responsible for rising popularity of LAAO procedures

Consulting fees and other vendor payments do not appear to be directly influencing U.S. physicians to implant more Watchman devices. Researcher Alexander Kolomaya, MD, discussed his team's findings on this topic.

AI healthcare doctor surgery procedure artificial intelligence
AI helps cardiologists terminate AFib for good with ablation

Advanced AI can provide real-time feedback to cardiologists, helping them deliver high-quality care. 

Innovation at work

Cardiovascular Business
5-year Evolut Low Risk Data: Durable clinical outcomes, outstanding valve performance

The late-breaking five-year results of the Evolut Low-Risk Trial presented at the American College of Cardiology (ACC) 2025 meeting in late March, showed positive results for the Evolut transcatheter aortic valve replacement (TAVR) system vs. surgical aortic valve replacement (SAVR). 

Sponsored by Medtronic

Around the web

Radiology Business
Tariffs threaten imaging access for patients, RBMA warns

Radiology practices are already operating on razor thin margins, with price increases prompting calls for congressional action to prevent further damage. 

Radiology Business
The impact of Trump tariffs on iodine contrast media costs

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?